After a two year experiment more questions need to be asked to move it on to the next stage. There are an awful lot of sudden deaths (SADS) occurring in younger fit and healthy people throughout the world. Athletes are collapsing on the pitch, or while they are competing, or dying in their sleep. To push this under the carpet and claim that this is nothing unusual, would be folly. The experiment will never come to it's conclusion if this is not followed up.
I always thought that any sudden death is followed by a post-mortem examination, to produce an autopsy which establishes the cause of that person dying.
Peter McCollough is calling for all sudden deaths to undergo an autopsy. He advises that for each case where there has been an exposure to the treatment, the study needs the dates, brands, lot numbers, history of cardiac or thrombembolic disease, hospital records if any, and autopsy findings. It is important to keep all original records.
In the meantime they push ahead with the programme, before all the essential data is recorded. Only then at the end of the experimental period can they claim that the product is safe. Anyone with any doubts would do well to hold back until they are clear in their own mind that they are taking the best course of action for themselves.
Catch ya later. ilona